Skip to content

Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health

Validation of a Mobile Health Application for Fall Risk Assessment in Parkinson's Disease: A Comparative Study Before and After Dopaminergic Medication Adjustment

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07257393
Acronym
PD_FALLRISK
Enrollment
100
Registered
2025-12-02
Start date
2025-12-01
Completion date
2026-06-30
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Parkinsonism

Keywords

Parkinson's disease, Fall risk, Motor fluctuation, Dopaminergic medication, Mobile health, Sit-to-Stand, Kinetikos Health App

Brief summary

This is a single-center, prospective observational study aiming to validate the Kinetikos Health App for fall risk assessment in PD patients undergoing dopaminergic medication adjustments.

Detailed description

Falls are common and disabling in PD. Dopaminergic medication effects on fall risk remain inconclusive. This study validates the Kinetikos Health App for objective fall risk assessment before and after medication adjustment.

Interventions

OTHERNo Intervention: Observational Cohort

No intervention.

Sponsors

Taipei Medical University Shuang Ho Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥20; 2. PD diagnosis (MDS criteria); 3. On levodopa monotherapy with motor fluctuations; 4. Planned to start opicapone or safinamide; 5. Consent provided.

Exclusion criteria

1. Atypical/secondary parkinsonism; 2. Moderate-severe dementia; 3. DBS/MRgFUS/neurosurgery within 6 months; 4. Severe comorbidities limiting test

Design outcomes

Primary

MeasureTime frame
Change in fall-risk index (Kinetikos Health App Sit-to-Stand)From baseline to 3 months

Secondary

MeasureTime frameDescription
UPDRSFrom baseline to 3 monthsChange in MDS-UPDRS axial score; Change in MDS-UPDRS Part II
Fall eventsFrom baseline to 3 monthsFall events during 3 months
LEDDFrom baseline to 3 monthsChange in LEDD

Countries

Taiwan

Contacts

Primary ContactChen-Chih Chung, MD
10670@s.tmu.edu.tw+886-2-22490088
Backup ContactChien Tai Hong, MD, PhD
15004@s.tmu.edu.tw

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026